Literature DB >> 2828592

Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease.

H Trachtman1, B Gauthier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828592     DOI: 10.1016/s0022-3476(88)80073-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  20 in total

1.  Management of congenital nephrotic syndrome.

Authors:  Larisa Kovacevic; Christopher J D Reid; Susan P A Rigden
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

3.  Renin-angiotensin-aldosterone system inhibitors in pediatric focal segmental glomerulosclerosis.

Authors:  Shreya Kangovi; Meredith Edwards; Stephen Woloszynek; Nandita Mitra; Harold Feldman; Bernard S Kaplan; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2011-11-25       Impact factor: 3.714

4.  Achieving remission of proteinuria in childhood CKD.

Authors:  Piero Ruggenenti; Paolo Cravedi; Antonietta Chianca; MariaRosa Caruso; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

5.  Long-term therapy with enalapril in patients with nephrotic-range proteinuria.

Authors:  W Proesmans; I V Wambeke; M V Dyck
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

6.  Influence of enalapril on experimental cyclosporin A nephrotoxicity.

Authors:  A Anarat; A Noyan; G Gonlusen; N Duman; D Tuncer
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

7.  Angiotensin converting enzyme inhibitor does not reduce proteinuria in an infant with congenital nephrotic syndrome of the Finnish type.

Authors:  R Birnbacher; E Förster; C Aufricht
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

8.  Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.

Authors:  Y Shapira; F Mor; A Friedler; A J Wysenbeek; A Weinberger
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

Review 9.  Evidence-based guidelines for the management of hypertension in children with chronic kidney disease.

Authors:  Janis M Dionne
Journal:  Pediatr Nephrol       Date:  2015-03-10       Impact factor: 3.714

Review 10.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.